One could alternatively interpret that the reduced latency to the dark in MPH treated Kv1.3−/− mice could be due to the delivery of a potent stimulant drug, rather than reduced anxiety, however, the MPH treated Kv1.3−/− mice spend equal amount of time in the light as WT mice, indicating this was not attributed to increased movement. Here, KCNA3 is linked to Anxiety.